EMBARK: A Phase 3b, Open-Label, Single-Arm, Safety Study to Evaluate the Long-Term Safety and Efficacy of Aducanumab in Eligible Participants With Alzheimer's DiseaseCarmen Castrillo-Viguera,Spyros Chalkias,Patrick Burkett,Shuang Wu, Huaihou Chen,Katie Harrison, Carol Yurgalevitch,Samantha Budd HaeberleinNEUROLOGY(2021)引用 2|浏览2暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要